Scarica l'app Stockscreener
1.66
0.00%
0.00
Dopo l'orario di chiusura:
1.65
-0.01
-0.60%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GERN Giù?
Forum
Previsione
Geron Corp Borsa (GERN) Ultime notizie
GERN Stock Price, Quote & Chart | GERON CORP (NASDAQ:GERN) - ChartMill
Geron (NASDAQ:GERN) Trading Up 9.7%What's Next? - MarketBeat
Geron Corporation’s Strategic Moves Amplify Stocks in Q1 2026 - StocksToTrade
Market Recap: Can Geron Corporation deliver consistent dividendsPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Geron (NASDAQ:GERN) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Aug Highlights: Can Geron Corporation be the next market leaderExit Point & Breakout Confirmation Trade Signals - baoquankhu1.vn
GERN Technical Analysis | Trend, Signals & Chart Patterns | GERON CORP (NASDAQ:GERN) - ChartMill
Geron Corp Stock: Biotech Investor Focus on RYTELO Commercialization and Valuation Gap Amid Market V - AD HOC NEWS
Geron Adds Biopharma Veterans As RYTELO Focus And Valuation Draw Attention - Yahoo Finance
Geron Corporation Form 8-K Filing Details for March 25, 2026: Company Information, Stock Symbol, and SEC Compliance 16 - Minichart
Vanguard (NASDAQ: GERN) discloses 0 share ownership after realignment - Stock Titan
Geron (NASDAQ: GERN) director granted 270,000 stock options at $1.57 strike - Stock Titan
Geron (GERN) director Constantine Chinoporos files initial Form 3 - stocktitan.net
Geron (GERN) grants director 270,000 stock options at $1.57 - Stock Titan
Geron (GERN) director Patricia Andrews submits initial insider ownership filing - Stock Titan
Geron appoints Patricia S. Andrews and Constantine Chinoporos to board of directors - Investing.com
Geron adds two directors with commercial expertise to board - Investing.com
[8-K] GERON CORP Reports Material Event - Stock Titan
Geron Announces Appointment of New Members to its Board of Directors - ChartMill
Geron Corp stock advances on imetelstat FDA approval momentum and pipeline updates - AD HOC NEWS
Geron's cancer screening patent rejected as non-patentable under Indian law - MLex
Geron (NASDAQ:GERN) Trading Up 8.6%Here's What Happened - MarketBeat
Geron’s Strategic Push: RYTELO’s Rising Global Ambitions - StocksToTrade
GERN SEC FilingsGeron Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Levi & Korsinsky Notifies Shareholders of Geron Corporation(GERN) - The National Law Review
Geron Corporation (NASDAQ:GERN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Six new Geron hires get stock options on 956,250 shares - Stock Titan
Geron (GERN) reports Q4 loss, misses revenue estimates - MSN
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Details RYTELO Growth Plan, $220M-$240M 2026 Sales Guide and MF Trial Catalyst at Barclays Conference - MarketBeat
Geron (NASDAQ:GERN) Shares Up 8.5%Should You Buy? - MarketBeat
Almitas Capital LLC Buys Shares of 946,323 Geron Corporation $GERN - MarketBeat
Geron (NASDAQ:GERN) Stock Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Geron Corporation (GERN) Reports Q4 EPS of (5c) - Insider Monkey
Assessing Geron (GERN) Valuation After US$150 Million Equity Offering And New Shelf Registration - simplywall.st
Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans - Investing.com
How The Geron (GERN) Story Is Shifting After Target Cut And New Equity Plans - Yahoo Finance
11 Fastest Growing Penny Stocks to Buy Right Now - Insider Monkey
Geron Earnings Call: Rytelo Growth Amid Profit Pressures - TipRanks
Geron Empowers Expansion with Rytelo’s Fuel - StocksToTrade
Geron (NASDAQ:GERN) Trading Up 10.9%Here's What Happened - MarketBeat
Geron Corporation $GERN Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Soleus files 5.2% stake in Geron (GERN) via master fund - Stock Titan
A Look At Geron (GERN) Valuation As Investors Weigh RYTELO Growth Against Recent Losses - simplywall.st
Is Geron (GERN) Using Its New ATM Program To Prioritize Flexibility Over Shareholder Dilution? - Yahoo Finance
Geron at TD Cowen: Strategic Growth and Market Expansion - Investing.com
Geron (NASDAQ: GERN) launches $150M ATM sales agreement with TD Cowen - Stock Titan
Geron 10-K: Revenue $183.9M, EPS (0.13) - TradingView
HC Wainwright Issues Optimistic Outlook for Geron Earnings - MarketBeat
Geron (GERN) 2025 Revenue Surges to $183.6M Driven by RYTELO Commercial Success - Yahoo Finance
Geron Corporation (NASDAQ:GERN) Q4 2025 Earnings Call Transcript - Insider Monkey
Geron (GERN) Pops on FDA Nod: Is This Small-Cap Biotech Now Underpriced? - AD HOC NEWS
HC Wainwright Weighs in on Geron's Q2 Earnings (NASDAQ:GERN) - MarketBeat
Geron shares drop after Q4 results miss estimates despite Rytelo growth - MSN
Geron Corp (GERN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments - Investing.com Canada
Geron Corp (GERN) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
Geron (GERN) Projects Strong Revenue and Manages Expenses for 20 - GuruFocus
Why Geron (GERN) Is Up 8.3% After Narrowing Losses And Boosting 2026 RYTELO Outlook - simplywall.st
Geron Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Geron (NASDAQ:GERN) Releases Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):